CHRGD+
LIVE

Serial Number

88576730

Owner

Lexaria Bioscience Corp.

First Use Date

Jul 31, 2019

Filing Date

Aug 13, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CHRGD+ Trademark

Serial Number: 88576730 • Registration: 7220814

CHRGD+ is a trademark filed by Lexaria Bioscience Corp. on August 13, 2019. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 33 (Wine & Spirits). The application is currently registered and active.

Owner Contact Info

Lexaria Bioscience Corp. (7 trademarks)

Phoenix, AZ 85021

Entity Type: 03

Trademark Details

Filing Date

August 13, 2019

Registration Date

November 21, 2023

First Use Anywhere

July 31, 2019

First Use in Commerce

July 31, 2019

Published for Opposition

July 25, 2023

Goods & Services

(Based on 44(e)) Chocolates, chocolate confections and candy, puddings, custards; non-alcoholic beverages, namely, coffee, coffee-based beverages, tea, cocoa-based beverages; beverage flavorings, namely, syrup for flavoring beverages; honey; salad dressings; snack food products, namely, granola-based snack bars, cereal-based energy bars, chocolate-based energy bars, chocolate-based meal replacement bars, crackers and cookies; flour and preparations made from cereals, namely, breads and pastries; condiments, namely, dipping sauces and marinades; seasonings

(Based on 44(e)) Providing educational services, namely, coaching, consulting, support and guidance services in the field of nutritional, mental and physical well-being, development and improvement by way of online chat rooms, on-line discussion groups, webinars, seminars and video conferences

(Based on Use in Commerce) (Based on 44(e)) Dietary, nutritional and herbal supplements and vitamins for general physical health and mental well-being for consumption by humans in swallowable, edible or drinkable form; dietary, nutritional and herbal supplements and vitamins for general physical health and mental well-being for consumption by animals in swallowable, edible or drinkable form; pharmaceutical preparations for the treatment of epilepsy, erectile dysfunction, glaucoma, high blood pressure, anxiety, nausea, nicotine addiction, drug addiction, alcohol addiction, gambling addiction, eating disorders, namely, bulimia nervosa, anorexia, obesity and hypothyroidism, migraines, headaches, joint pain, nerve pain, multiple sclerosis, inflammation, depression, insomnia, acne, diabetes, schizophrenia, cancer, menopause, premenstrual syndrome, heart conditions, blood clots, incontinence, hormonal imbalance, high or low thyroid conditions, viral diseases, namely, colds, flus, herpes, hepatitis, human immunodeficiency viruses and acquired immune deficiency syndrome, sinus congestion, allergies, baldness, thinning hair, sexual stamina, dental and oral diseases, neurological disorders, namely, cerebral palsy, Huntington's Disease, Alzheimer's and Parkinson's Disease; veterinary pharmaceutical preparations for the treatment of periodontal diseases, respiratory and reproductive diseases, arthritis, muscle soreness and sprains, bacterial infections, infectious diseases, namely, respiratory infections, eye infections, topical infections, swine dysentery, bacterial enteritis, Bluecomb and pneumonia, nutritional muscular dystrophy, parasites, vitamin deficiencies and udder care; medicated topical creams, lotions, gels, balms, oils and ointments for human use for lip and skin dryness, cold sores, burns, hives and skin diseases, namely, rosacea, eczema, psoriasis and warts

(Based on 44(e)) Cosmetics, namely, skin creams, skin lotions, face and body washes, and under eye treatments in the nature of beauty serums; sunscreen creams; skin lightening creams; skin moisturizers; skin care products, namely, non-medicated skin serum; non-medicated foot creams; skin toners; astringents for cosmetic purposes; non-medicated lip care preparations

(Based on 44(e)) Wine; spirits, namely, vodka, rum, gin, distilled blue agave liquor, whiskey and brandy; prepared alcoholic cocktails and alcoholic cocktail mixes

(Based on 44(e)) Beer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 21, 2023 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 13, 2023 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 13, 2023 AITU
NOTICE OF ALLOWANCE CANCELLED
Sep 19, 2023 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Sep 19, 2023 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 11, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 28, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 28, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 28, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 27, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 25, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 25, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 25, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 13, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 7, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 7, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jul 7, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2022 CRFA
ASSIGNED TO LIE
Jul 7, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 6, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 5, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 5, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 5, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 24, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 4, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 4, 2021 GNSL
SUSPENSION LETTER WRITTEN
Dec 4, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 26, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 26, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 26, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 26, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 20, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 23, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 23, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 23, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 18, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 3, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 3, 2020 GNSL
SUSPENSION LETTER WRITTEN
Sep 3, 2020 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 14, 2020 RCCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 7, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 14, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 14, 2020 GNSL
SUSPENSION LETTER WRITTEN
Feb 14, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 9, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 17, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 17, 2019 GNSL
SUSPENSION LETTER WRITTEN
Dec 17, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 27, 2019 CRFA
ASSIGNED TO LIE
Nov 25, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 19, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 18, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 18, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 18, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 12, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 29, 2019 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2019 NWOS
NEW APPLICATION ENTERED
Aug 16, 2019 NWAP